Jonathan Farhi

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study

Emmanuel Bachy, John F. Seymour, Pierre Feugier et al. · Journal of Clinical Oncology · 2019 · 278 citations · Full text

Medicine, Immunology, Oncology +10

Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin’s lymphoma undergoing allogeneic haematopoietic cell transplantation—a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

Jordan Gauthier, Xavier Poiré, Anne‐Claire Gac et al. · Bone Marrow Transplantation · 2018 · 43 citations · Full text

Medicine, Hematology, Oncology +17

R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma

Kamel Laribi, Nathalie Denizon, Delphine Bolle et al. · Annals of Hematology · 2016 · 42 citations

Medicine, Geriatric Medicine, Oncology +7

Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive Care

Corentin Orvain, François Beloncle, Jean‐François Hamel et al. · Transplantation · 2016 · 25 citations

Medicine, Hematology, Surgery +16

Impact of front line relative dose intensity for methotrexate and comorbidities in immunocompetent elderly patients with primary central nervous system lymphoma

Jonathan Farhi, Kamel Laribi, Corentin Orvain et al. · Annals of Hematology · 2018 · 23 citations

Pharmacy, Oncology, Pharmacotherapy +11